Ranked among the 5,000 newest matching findings; add words or filters to narrow the search.
Antihistamine‐decongestant leads to higher adverse effects: dry mouth compared with placebo (high certainty).
Antihistamine‐decongestant showed no clear difference in adverse effects: insomnia compared with placebo (moderate certainty).
Antihistamine‐decongestant showed no clear difference in adverse effects: gastrointestinal upset compared with placebo (moderate certainty).
Antihistamine‐analgesic probably leads to lower global evaluation compared with placebo (moderate certainty).
Antihistamine‐analgesic showed no clear difference in adverse effects: drowsiness, hypersomnia, and excessive sleepiness compared with placebo (low certainty).
Analgesic‐decongestant probably leads to lower global evaluation compared with placebo (moderate certainty).
Proton pump inhibitor treatment showed no clear difference in mortality ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty).
Proton pump inhibitor treatment showed no clear difference in rebleeding ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty).
Proton pump inhibitor treatment showed no clear difference in surgery ‐ within 30 days compared with H2RA, placebo or no treatment (low certainty).
Proton pump inhibitor treatment showed no clear difference in proportion of participants with stigmata of recent haemorrhage at… compared with H2RA, placebo or no treatment (low certainty).
Proton pump inhibitor treatment probably leads to lower endoscopic haemostatic treatment at index endoscopy compared with H2RA, placebo or no treatment (moderate certainty).
Pregabalin may leads to higher 50% or greater reduction in seizure frequency ‐ ITT analysis compared with placebo (low certainty).
It is very uncertain whether pregabalin changes adverse effect: headache compared with placebo (very low certainty).
Pregabalin showed no clear difference in adverse effect: nausea compared with placebo (low certainty).
Pregabalin may leads to higher adverse effect: somnolence compared with placebo (low certainty).
Pregabalin may leads to higher adverse effect: weight gain compared with placebo (low certainty).
Pregabalin probably leads to higher treatment withdrawal for any reason compared with placebo (moderate certainty).
Pregabalin probably leads to higher treatment withdrawal due to adverse effects compared with placebo (moderate certainty).
Pregabalin may leads to higher adverse effect: ataxia compared with placebo (low certainty).